Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001312326-18-000002

Options or other derivatives

  • Director bought 50,000 shares

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Baxter Nicholas W Director 2018-05-31 Purchase · Options +50,000 160,000 D: show line 1 in the form
Loading xslF345X03/primary_doc.xml…